Equol: Difference between revisions
CSV import |
No edit summary |
||
| Line 34: | Line 34: | ||
{{stub}} | {{stub}} | ||
== Equol == | == Equol == | ||
<gallery> | <gallery> | ||
File:Equol_structure.png|Equol structure | File:Equol_structure.png|Equol structure | ||
</gallery> | </gallery> | ||
Latest revision as of 20:28, 16 March 2025
Equol is a metabolite of isoflavones, a type of phytoestrogen, that is produced by the action of gut microbiota. It is a non-steroidal estrogen that has been the subject of numerous studies due to its potential health benefits, particularly in relation to menopause, osteoporosis, and cardiovascular disease.
History[edit]
Equol was first isolated in 1982 from the urine of individuals who consumed soy products. It was named after the chemical structure of the compound, which is a 7-hydroxy-3-(4'-hydroxyphenyl)-chroman.
Production[edit]
Equol is produced in the gut by the action of certain types of bacteria, including Lactobacillus and Bifidobacterium. These bacteria convert dietary isoflavones, particularly daidzein, into equol.
Health Benefits[edit]
Numerous studies have suggested that equol may have a number of health benefits. These include:
- Menopause: Equol has been shown to alleviate some of the symptoms of menopause, including hot flashes and night sweats.
- Osteoporosis: Some research suggests that equol may help to prevent bone loss and reduce the risk of osteoporosis.
- Cardiovascular Disease: Equol may help to reduce the risk of cardiovascular disease by improving blood vessel function and reducing inflammation.
Safety and Side Effects[edit]
Equol is generally considered safe, with few reported side effects. However, as with any supplement, it should be used under the supervision of a healthcare provider.
